The rising prevalence of Autism Spectrum Disorder to boost Autism Spectrum Disorder Therapeutics Market growth

Autism Spectrum Disorder Therapeutics
Autism Spectrum Disorder Therapeutics 


Autism Spectrum Disorder Therapeutics Market Size, Share & Trends Analysis Report By Treatment Type (Stimulants, Antipsychotic Drugs), and by Region (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Outlook, Size, Share and Opportunity Analysis 2023 – 2030

The global Autism Spectrum Disorder Therapeutics Market is estimated to be valued at US$ 2.05 billion in 2022 and is expected to exhibit a CAGR of 6.1 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Autism Spectrum Disorder is a situation that is linked to the development of the brain that affects how a person receives things and interacts with others, the problems in social communication, and the active participation of a person in society. Autism Spectrum Disorder Therapeutics also comprises of restricted and repetitive methods of behavior such as anger. Autism Disorder Treatment comprises the situations that were earlier regarded as Asperger’s syndrome, an unclear method of the pervasive growth ailment. Few people still utilize the word Asperger’s syndrome in which is usually thought to be a very slight end of the Autism Disorder Treatment.

Competitive Landscape:

Key players involved in the growth of global Autism Spectrum Disorder Therapeutics Market are Curemark LLC, Johnson & Johnson Services Inc., Axial Therapeutics Inc., Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Merck & Co., Inc., Yamo Pharmaceuticals, Novartis AG and Pfizer Inc.

Market Key Drivers:

The rising prevalence of Autism Spectrum Disorder is expected to drive the growth of the global Autism Spectrum Disorder Therapeutics Market. For instance, as per CDC around 1 in every 44 children suffer from Autism Spectrum Disorder.

The rising R&D of new medications to cure the disease in patients in projected to fuel the growth of the global Autism Spectrum Disorder Therapeutics Market. For instance, in July 2022, AbbVie Inc. and Otsuka Pharmaceutical Co., Ltd. conducted a trial on phase II of the medicine Vraylar and Rexulti respectively, in patients suffering from autism.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Autism Spectrum Disorder Therapeutics Market due to the rise in surge of pandemic.  The rising cases has led to the shift of physicians from treating other disorder towards curing Covid-19 patients. The lack of physicians, shortage of beds and the delay in treatment of others disorders in the healthcare system have impeded market growth.

Key Takeaways:

The global Autism Spectrum Disorder Therapeutics Market is expected to exhibit a CAGR of 6.1 % during the forecast period due to rising research and survey regarding the safety of the autism drug in patients. For instance, in March 2022, Stalicla effectively finished phase 1b trials of medicine candidate STP1 and there were positive outcomes with decreasing symptoms in patients with Autism Spectrum Disorder.

Among regions North America, Asia Pacific, and Europe are anticipated to witness robust growth in the global Autism Spectrum Disorder Therapeutics Market owing to the rising prevalence of Autism Spectrum Disorder, increasing R&D, rising collaborations, and partnerships. For instance, as per Zynerba Pharmaceuticals, in November 2022, over 1.4 million were suffering from Autism Spectrum Disorder in U.S. 

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

The rising fungi infections such as athlete’s foot to boost the Antifungal Drugs Market growth

Image
  Antifungal Drugs Market Global Antifungal Drugs Market, by Drug Type (Echinocandins, Polyenes, Allylamines, Azoles, and Others), by Indication (Aspergillosis, Dermatophytosis, Candidiasis, Mucormycosis, and Others), by Dosage Form (Powders, Ointments, Drugs, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028 The global Antifungal Drugs Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: There are several kinds of antifungal drugs, out of which in few people can be advised to have over-the-counter (OTC) and few that are prescribed by the physician. Someone who is very weak and has a low immune system and assume to have fungal infection should consult a physician instantly. Yeasts, Molds, and mu...
Read more